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Abstract Six members of the herpesvirus family cause
well-described neurologic disease in children: herpes
simplex virus-1 (HSV-1), herpes simplex virus-2 (HSV-2),
varicella-zoster (VZV), Epstein-Barr (EBV), cytomegalovi-
rus (CMV), and human herpes virus-6 (HHV-6). When
herpesviruses infect the central nervous system (CNS), the
clinical presentation is non-specific and often confounding.
The clinical urgency is often underscored by progressive
neurologic deficits, seizures, or even death, and prompt
diagnosis and treatment rely heavily on neuroimaging. This
review focuses on the spectrum of cerebral manifestations
caused by these viruses, particularly on non-congenital
presentations. Recent advances in our understanding of
these viruses are discussed, including new polymerase
chain reaction techniques that allow parallel detection,
which has improved our recognition that the herpesviruses
are neurotropic and involve the CNS more often than
previously thought. Evolving knowledge has also better
elucidated viral neuropathology, particularly the role of
VZV vasculitis in the brain, HHV-6 in febrile seizures, and
herpesvirus reactivation in immunosuppressed patients. The
virology, clinical course, and CNS manifestations of each
virus are reviewed, followed by descriptions of neuro-
imaging findings when these agents infect the brain.
Characteristic but often subtle imaging findings are dis-
cussed, as well as technical pearls covering appropriate use
of MRI and MRI adjuncts to help differentiate viral
infection from mimics.
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Introduction
All of the members of the herpesvirus family are large,
enveloped, double-stranded DNA viruses. The name “her-
pes” itself is derived from the Greek word herpein [1],
which means “to creep,” an appellation that reflects the
important theme and unique ability of these viruses to cause
a permanent, lifelong infection in their host. After primary
infection, the herpesviruses persist in various cells of the
body and maintain the ability to reactivate during periods of
relative immunosuppression. Of the eight members of the
herpesvirus family, six are well-known etiologic agents of
central nervous system (CNS) disease: herpes simplex
virus-1 (HSV-1), herpes simplex virus-2 (HSV-2), varicel-
la-zoster virus (VZV), Epstein-Barr virus (EBV), cytomeg-
alovirus (CMV), and human herpes virus-6 (HHV-6). These
viruses are ubiquitous and in most cases infect a large
percentage of the population with only mild, self-limiting
symptoms. Besides a tendency to remain latent, neuro-
tropism is another characteristic shared by the herpesviruses
[2, 3]. After initial infection, these viruses remain latent in
the nerves, later seeding the CNS by diffusing across
endothelial cells of cerebral vessels or by traveling
retrograde along the nerves of the meninges [4–6]. These
different mechanisms of entry are important to understand,
because they influence the patterns of abnormalities seen
with neuroimaging.
CNS involvement by the herpesviruses can occur in
several settings. Congenital transmission is fairly common
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in the case of CMV but also occurs with some frequency in
HSV-1 and HSV-2. Vertical, non-congenital transmission is
important in the epidemiology of HSV-2, and to a lesser
degree HSV-1. HHV-6 have been increasingly recognized
as agents of CNS disease in infants, particularly as a major
cause of febrile seizures. Occasionally, unvaccinated but
immunocompetent children with chickenpox will have
CNS complications, and VZV is certainly important in
children with suppressed immune systems. Finally, al-
though EBV seropositivity is almost universal and only
rarely causes CNS disease, EBV encephalitis often presents
with acute status epilepticus [7] and is the most common
agent to mimic herpes simplex virus encephalitis (HSE) [8].
New polymerase chain reaction (PCR) techniques have
dramatically improved the sensitivity of detecting the
herpesviruses [9] by allowing parallel PCR detection of
all six aforementioned herpesviruses with a single sample
of CSF [9–11]. The increased ability to diagnose herpesvi-
rus infection by PCR does not mitigate the importance of
neuroimaging. Indeed, MRI findings often provide the
impetus to perform PCR. Several patients have been
reported to have MRI findings highly suggestive of HSE
but negative PCR. Presumptive treatment was begun based
on MRI findings and later PCR test confirmed HSV
infection [12]. In addition, the early use of MRI and MRI
adjuncts such as diffusion-weighted imaging (DWI) and
magnetic resonance spectroscopy (MRS) can help identify
or exclude an alternative diagnosis in a patient with
suspected viral encephalitis [13].
Herpes simplex viruses, types 1 and 2
Virology, clinical course, and CNS manifestations
There are two serotypes of HSV: HSV-1 and HSV-2. For
practical purposes, HSV-1 typically involves the skin and
mucosa of the face while HSV-2 is associated with genital
infection. Because neonates usually acquire the infection
during birth, neonatal herpes, which can cause CNS
complications, is usually secondary to HSV-2. In contradis-
tinction, the most common etiology of HSE in non-neonatal
children is reactivation of HSV-1 [14]. Both serotypes are
capable of causing congenital infection [5, 15].
Congenital HSV
True congenital HSV infection, i.e. transplacental transmis-
sion of the virus by the mother to the fetus, accounts for
only 5–10% of “neonatal herpes.” Congenital infection is
usually caused by HSV-2 [16, 17] and is apparent within
the first days of life. In these cases, the virus has crossed the
placenta to infect the newborn and can be found in amniotic
fluid and placental tissue [18, 19]. Affected neonates
present with a combination of skin lesions, chorioretinitis,
microcephaly, and/or hydranencephaly [5, 15]. This con-
genital presentation differs from neonatal herpes, and
because it is outside the scope of this review, will not be
discussed in further detail.
Neonatal HSV
The incidence of neonatal herpes is difficult to track
because it is not a reportable disease, and HSV-1 and
HSV-2 seroprevalence varies regionally. Most sources
quote an incidence of one per 3,000 to 20,000 live births
[20]. In contradistinction to congenital infection, which
presents within the first few days of life, neonatal herpes
results from contact with infected lesions or secretions
during or shortly after birth [5, 15, 16, 21], and presentation
is delayed for 2–4 weeks [5]. Children can contract the
virus from an asymptomatic mother or even from close
contact with caregivers during the perinatal period [15].
Neonatal HSV infection is divided into three categories:
skin-eye-mouth (SEM) disease, CNS disease, and dissem-
inated infection [15, 22], although there is clinical overlap,
particularly of the latter two manifestations. Animal models
have shown that cutaneous contraction of the virus results
in SEM or mild disseminated disease, both with a relatively
benign course. Individuals infected through the mucous
membranes, respiratory tract, or eyes develop disseminated
and/or CNS disease and have increased morbidity and
mortality [23, 24]. Approximately 30% of all infected
neonates develop CNS manifestations, presenting with
seizures, irritability, lethargy, and/or fever [5, 15, 22].
Approximately two-thirds of neonatal herpes encephalitis is
caused by infection with HSV-2 [15] and the prognosis is
worse for these patients. In a study comparing the long-
term outcome of treated neonatal herpes encephalitis,
infants infected with HSV-2 had higher morbidity. Whereas
children with HSV-1 CNS disease (n=9) were normal at
follow-up, those with HSV-2 infection (n=15) had in-
creased rates of microcephaly, seizures, cerebral palsy, and
mental retardation [25]. It is recommended that neonates
with herpes encephalitis be treated at higher doses than
adults and children with HSE [26].
Non-neonatal herpes simplex encephalitis
Non-neonatal HSV is yet another entity, with unique
clinical and imaging features compared to neonatal HSV
infection [27]. To differentiate these two patient groups,
throughout this article CNS manifestations in non-neonatal
herpes will be referred to as HSE. HSE is the most common
cause of non-epidemic focal encephalitis in children older
than 6 months [14, 28, 29], and 25–30% of cases occur in
950 Pediatr Radiol (2007) 37:949–963
children [30]. HSE is usually caused by HSV-1 and is the
manifestation of reactivated disease. HSV-1 is a ubiquitous
virus that rarely causes neurologic complications. Children
usually become infected with the virus early in life from direct
contact with the secretions or lesions of infected individuals
(who may or may not be symptomatic). The primary infection
is more often asymptomatic, and likewise, the virus is
typically shed from an asymptomatic individual. Gingivosto-
matitis is the second most common presentation of the
primary viremia and is self-limiting. After primary infection,
the virus persists in a latent form within the trigeminal sensory
ganglion [6]. By unclear mechanisms, the virus occasionally
reactivates and can travel retrograde along branches of the
trigeminal nerve, along the ventral leptomeninges, and infect
the brain, particularly the frontal and temporal lobes [5, 6].
This mechanism of entry, perhaps in concert with cellular
tropism [2], accounts for the typical involvement of the limbic
system in HSE discussed below. Patients with reactivation of
HSV-1 typically present with antecedent fever and headache.
Those with encephalitis have a combination of seizures,
personality changes, acute mental status changes, and focal
neurologic deficits [30], whereas those with meningitis
typically lack focal neurologic abnormalities [29]. Early
detection and diagnosis of HSV-1 encephalitis is crucial, as
prompt administration of acyclovir can dramatically reduce
morbidity and mortality [30]. Excellent recent reviews of
pediatric [31] HSE [14] are available.
Neuroimaging findings
Neonatal herpes
In contrast to HSE seen in older children and adults,
neonatal herpes rarely is hemorrhagic [5, 27] and the
medial temporal and inferior frontal lobes are typically
spared [4, 5, 32, 33]. CT of neonatal herpes encephalopathy
shows patchy low density throughout the periventricular
white matter [4, 32, 34] with corresponding T1-W
hypointensity and T2-W hyperintensity on MRI. Proton
density scans can best show the signal changes in neonates
because increased T2-W signal can be hard to visualize on
a background of immature unmyelinated white matter,
which itself has high T2-W signal. Early changes of
neonatal herpes might also be better seen on DWI as areas
of restricted diffusion in the periventricular white matter [5,
35, 36] (Fig. 1). MRS can help narrow the differential by
revealing decreased N-acetyl aspartate (NAA), elevated
excitatory neurotransmitters, and possibly elevated lactate
[5]. Post-contrast imaging is usually negative but occasion-
ally demonstrates mild meningeal enhancement [5, 34]. As
the disease progresses, some neonates have increased
density of the cortex, which on MR is seen as increased
T1-W and decreased T2-W signal. In the correct setting,
this is a fairly specific pattern [5, 32] and is iatrogenic, the
sequela of retained iodinated contrast agent rather than
hemorrhage or calcification [37, 38]. Several months later,
there is true gyriform calcification of the cortex, seen in
concert with cortical thinning, white matter atrophy, and
multicystic encephalomalacia [5, 39, 40].
Herpes simplex encephalitis and meningitis
Although patients with HSE occasionally have normal MRI
scans, the majority have imaging findings in the inferome-
dial temporal lobes [13]. Indeed, because PCR is not 100%
sensitive [28], MRI can sometimes identify patients with
HSE in whom the PCR is initially negative. Weil et al. [12]
documented three patients in whom initial PCR was
negative, but because of high clinical suspicion and
compelling MRI findings, the patients were presumptively
Fig. 1 Images of a 12-day-old neonate with disseminated HSV
confirmed by PCR who presented with prolonged apneic episodes and
“jitteriness.” His delivery was uncomplicated, he was previously
healthy, and his mother had no history of herpes. a Axial FLAIR
image shows scattered hyperintense lesions in the bilateral periven-
tricular white matter (arrows). b DWI at the same level shows that
these lesions have restricted diffusion (arrows). c Dark signal on the
corresponding apparent diffusion coefficient map indicates that this is
true diffusion restriction rather than “T2 shine-through”
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treated for HSE. All three patients had MRI abnormalities
in the temporal lobes and later had positive PCR results.
The spectrum of imaging abnormalities in HSE reflects the
edema, hemorrhage, and necrosis seen pathologically.
Similarly, the disease distribution in the inferior frontal
and inferomedial temporal lobes and insular cortex [13]
lends credence to the proposed route of entry into the brain
along small branches of the trigeminal nerve.
CT scans can be normal or show non-specific areas of
hypodensity in the inferior frontal and inferomedial
temporal lobes [4]. Findings can be bilateral or unilateral
but are usually asymmetric. MRI better demonstrates
abnormalities in the aforementioned areas with characteris-
tic signal changes also involving the limbic system and
insular cortex. The cingulate gyrus, basal ganglia, and
cortex of the parietal and occipital lobes are less frequently
involved [13, 41]. T2-W images show swelling and
increased signal intensity in the brain parenchyma. The
corresponding areas have decreased T1-W signal and
variable enhancement [4] (Fig. 2). Petechial hemorrhage is
typical in HSE and can manifest on imaging studies as T1-
W shortening or blooms of hypointensity on gradient
recalled echo (GRE) scans [42]. Increased T1-W signal
can be seen in a linear, gyriform configuration in the acute
stage. This T1-W shortening represents cortical hemorrhage
rather than laminar necrosis and is found to have resolved
on follow-up imaging [43, 44]. The cytotoxic damage of
HSE is well imaged with DWI. Areas of diffusion
restriction have been shown to be one of the earliest signs
of HSE [45, 46].
Leonard et al. [27] have described another pattern of
non-neonatal HSE that occurs in infants. Their patients with
documented HSV-1 lacked the typical findings of periven-
tricular white matter abnormalities seen in neonatal herpes.
On the other hand, imaging showed minimal hemorrhage
and no involvement of the medial temporal or inferior
frontal lobes, findings that are characteristic of HSE in
older children. Instead, these infants had signal abnormal-
ities that mirrored the anterior, middle, or posterior cerebral
artery vascular territories. There was slight hypointensity
and cortical thickening on T1-W imaging and
corresponding increased T2-W signal in the hemispheric
cortex and underlying white matter (Fig. 3). After contrast
agent administration, diffuse enhancement was shown in
the cortex but not in the overlying meninges. Absence of
meningeal enhancement is peculiar if the virus’ only mode
of CNS entry is spread along the meningeal nerves. These
observations have led some authors to hypothesize that
HSV has a different route of entry to the CNS in younger
children than in older children, spreading hematogenously
across an immature blood–brain barrier rather than along
nerve branches [4, 27].
HSV differential diagnosis and summary
HSV-1 and HSV-2 infections represent the archetype for
herpesvirus CNS disease. The protean nature of the virus
family is reflected in the spectrum of clinical presentations
and imaging findings seen with CNS HSV infection. The
differing mechanisms of CNS entry lead to the varied
presentations and to the different neuroimaging appear-
ances. The differential diagnosis of any given case will vary
depending on the type of herpes encephalitis. In the older
child with HSE, there is a pattern of non-enhancing cortical
Fig. 2 HSV-1 encephalitis in a
patient with fever and seizures
of new onset. a Axial FLAIR
image shows abnormal signal in
a typical limbic distribution of
HSE (large arrows). Abnormal
signal in the left thalamus is also
seen (small arrow). The signal
abnormalities were best seen on
FLAIR because the CSF signal
is suppressed. b On the T1-W
image after contrast agent ad-
ministration, there is little en-
hancement in the parenchyma
compared to that in the
meninges and engorged veins
(arrows). Note the edema and
mid-line shift toward the right
seen on both images
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and subcortical signal abnormalities. The differential con-
siderations in this setting would include other viral
encephalitides, acute demyelinating encephalomyelitis
(ADEM) and, especially in a seizing child, tubers of
tuberous sclerosis. Diffusion abnormalities seen in HSV
infection can lessen the suspicion for ADEM, while a lack
of other stigmata of tuberous sclerosis would exclude that
entity. Older children with HSE have signal abnormalities
in the medial temporal and inferior frontal lobes, insula, and
cingulate gyrus that distinguish HSV among other causes of
encephalitis. Further specificity derives from the fact that
HSV infection often causes hemorrhage, which is seen as
increased signal on T1-W images or decreased signal on
GRE sequences because of deoxyhemoglobin. DWI is also
an excellent adjunct when there is suspicion of HSE
because this aggressive cytotoxic encephalitis can cause
brain necrosis, which, when imaged early, manifests as
diffusion restriction [45, 46]. Of course, with diffusion
abnormalities, stroke (both venous and arterial) and
mitochondrial cytopathy enters into the differential diagno-
sis. In the case of HSV, the hypothesized mechanism of
spread along the meningeal nerves in an older child is
helpful. One would not expect ischemia to center along the
insular cortex but rather to have a more classic vascular
territory pattern. Magnetic resonance arteriography (MRA)
and venography would be of benefit when trying to
differentiate HSE from stroke. When the MRI findings
raise the suspicion of HSV infection, it is important to
impress upon referring clinicians the likelihood of HSE, as
some authors advocate starting acyclovir even in cases of a
negative initial PCR when the imaging findings are
compelling [12].
Varicella-zoster virus
Virology, clinical course, and CNS manifestations
The natural history of VZV infection has been well
described [47, 48]. VZV enters the body through the
respiratory tract or conjunctiva. The primary viremia occurs
within 4–6 days and is followed about 10 days later by a
mild, self-limiting viral exanthema. Like other herpes
viruses, VZV remains latent within the trigeminal ganglion
[49]. CNS complications are the most common cause of
VZV-associated hospitalization in otherwise healthy chil-
Fig. 3 Images of a 17-month-
old with HSE who presented
with fever and seizure. Axial
T2-W (a) and coronal FLAIR
(b) images show cortical thick-
ening in the right high fronto-
parietal lobes with increased
signal in the cortex and under-
lying white matter. The distri-
bution is not typical of HSE as
seen in older children but rather
involves the cortex and subcor-
tical white matter in the territory
of the posterior middle cerebral
artery. c, d The vascular territory
pattern of HSE peculiar to
infants and young children is
further emphasized in a second
infant with HSE who had signal
abnormalities (arrows) in the
posterior portion of the left
anterior cerebral artery distribu-
tion seen on coronal (c) and
axial (d) T2-W images
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dren [50] and occur with an incidence of 1% [51]. Although
the incidence of chickenpox has decreased in the 10 years
since use of the VZV vaccine became widespread [52], the
increasing use of PCR has increased awareness of VZV as
an important etiologic agent of acute CNS symptoms [53,
54]. CNS complications of VZV infection include acute
cerebellar ataxia, encephalitis, and vasculitis [3, 50, 55–58].
As elucidated below, these complications are each sequelae
of vascular involvement by the virus rather than the result
of completely separate disease pathways.
Cerebellitis
Cerebellar ataxia is a clinical syndrome of headache,
vomiting, irritability, and gait abnormalities that is usually
self-limiting. Acute cerebellar ataxia occurs in the days or
weeks following primary VZV infection and was previous-
ly considered an immune-mediated process. It is now
known that acute cerebellar ataxia results from varicella’s
cerebellar neurotropism and corresponds to VZV cerebelli-
tis pathologically and radiographically [3, 31, 57, 59].
Multifocal leukoencephalopathy
The term VZV encephalitis is really a misnomer. VZV does
not cause a primary encephalitis [56] but rather directly
infects cerebral vessels, resulting in a small-vessel arterio-
pathy, which is more properly referred to as VZV
multifocal vasculopathy or leukoencephalopathy [3, 53,
56, 60]. We prefer the latter term because it better reflects
the imaging findings that help the radiologist form a useful
differential diagnosis. VZV multifocal leukoencephalop-
athy is the most common CNS complication of chickenpox.
In a study of 38 patients (mean age 8.6 years) with VZV
infection and acute neurologic symptoms, it was the most
common presentation, occurring in 79% of patients [58].
Clinically, the presentation of leukoencephalopathy varies.
Signs and symptoms are non-specific and resemble those
seen in other viral encephalitides. Children can present with
headache, confusion, and/or fever [3, 60], or present with
more profound CNS complications such as mental status
changes, seizure, stroke, or focal deficits [56]. Focal
neurologic deficits are caused by ischemia and are usually
subacute symptoms of hemiplegia, aphasia, and/or visual
deficits. Patients are commonly immunocompromised from
transplantation or HIV infection [60].
Vasculitis
Throughout the literature, large-vessel VZV vasculopathy is
referred to as herpes zoster ophthalmicus, granulomatous
angiitis, VZV vasculitis, and VZV-associated stroke. Patho-
logically, the spectrum ranges from necrotizing arteritis with
aneurysms to vascular occlusion with or without inflammato-
ry changes [3]. Globally, we refer to this spectrum as VZV
vasculitis. Varicella is a well-documented risk factor for
ischemic stroke in children and is responsible for approxi-
mately one-third of childhood strokes. Children with stroke
from VZV vasculitis tend to be healthier than children with
stroke from other causes [55], and, in contrast to children
with multifocal leukoencephalopathy, they tend to be
immunocompetent. The vasculitis presents weeks to months
after the rash has resolved and presents as an acute focal
deficit [60, 61]. VZV-associated stroke often causes acute
hemiparesis in the setting of basal ganglia infarction, a fairly
characteristic presentation in pediatric stroke [55, 61–63].
Neuroimaging findings
Cerebellitis
The imaging literature of VZV cerebellitis is sparse because
cerebellar ataxia was previously considered an immune-
mediated process and the diagnosis was therefore based on
laboratory and clinical findings. Although little emphasis has
been placed on VZV cerebellitis, multiple investigators have
recently described characteristic neuroimaging findings of
cerebellitis in children with acute cerebellar ataxia and
serologically confirmed acute VZV infection [31, 59]. Mass
effect is seen on CT scans, and MRI reveals diffuse or focal
areas of decreased T1-W and increased T2-W signal in the
cerebellum and/or cerebellar peduncles [63, 64] (Fig. 4).
Multifocal leukoencephalopathy
VZV multifocal leukoencephalopathy has two imaging
patterns: a non-specific pattern similar to other encephalit-
ides and the second with a clear arterial distribution.
Although these patterns can be superimposed, the latter
betrays true nature of VZV infection as a primary vasculop-
athy and is therefore discussed separately below. The non-
specific pattern typical of other encephalitides is seen when
VZV involves the smaller peripheral vessels of the brain.
Neuroimaging demonstrates diffuse, multifocal cortical and
subcortical abnormalities that are non-enhancing and low
density on CT scans. MRI reveals edema in the cerebral
cortex and underlying white matter with low T1-W and high
T2-W signal changes [3, 4, 53, 56, 60, 65] (Fig. 5).
Vasculitis
When varicella involves more central vessels, neuroimag-
ing more clearly shows an arterial distribution with
different patterns based on the size of the affected vessels.
Because VZV has a predilection for small vessels of the
basal ganglia, isolated ischemia is characteristically seen
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with VZV vasculitis [55, 63]. Basal ganglia ischemia can
be unilateral or bilateral and manifests as hypodense, non-
enhancing lesions on CT that have low T1-W and high T2-
W MR signal [53, 61, 65, 66]. VZV can also infect large
cerebral vessels, causing hemispheric strokes [53, 56, 61],
and DWI will show diffusion restriction immediately after
symptoms appear. Another important MRI adjunct is MRA
[61]. MRA and CT angiography are highly sensitive for
flow abnormalities and less invasive than conventional
angiography. In VZV vasculitis, arterial imaging demon-
strates irregularity, segmental narrowing, beading, or
stenosis involving the anterior and middle cerebral arteries
and their branches [4, 56, 60, 61, 63]. The carotid and
posterior circulation are less commonly involved [61].
VZV summary
Whenever a child with recent chickenpox or a VZV-exposed
non-immunized or immunosuppressed child presents with
acute neurologic symptoms, the diagnosis of VZV infection
should be considered. Likewise, a history of chickenpox
should be sought and VZV vasculitis considered when an
Fig. 4 Axial FLAIR image through the posterior fossa in a patient
with recent chickenpox shows non-specific findings of VZV cerebel-
litis and rhombencephalitis, including a mild mass effect and increased
FLAIR signal in the pons, cerebellar peduncles and cerebellum
Fig. 5 VZV leukoencephalop-
athy in a child with chickenpox
and mental status changes. a A
non-enhanced CT image shows
a subtle area of low attenuation
in the right anterior globus pal-
lidus, putamen, and anterior
limb of the internal capsule
(arrow). b T2-W image shows
edema and increased signal in
the region of the CT abnormal-
ities (large black arrow), as well
as the bilateral caudate heads
(small black arrows) and scat-
tered throughout the cerebral
cortex and subcortical white
matter (white arrows). These
areas were low signal on T1-W
images and did not enhance (not
shown). c Short echo proton
MRS (TE 35 ms) over the right
basal ganglia demonstrates de-
creased NAA (large arrow),
elevated excitatory neurotrans-
mitters (short arrows), and a
prominent lactate peak (thin ar-
row). d A 3-D time-of-flight
MR angiogram shows no ab-
normalities in the large cerebral
vessels because VZV leukoen-
cephalopathy is caused by
small-vessel involvement rather
than large-vessel abnormalities
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otherwise healthy child presents with stroke and MRI
abnormalities in the basal ganglia and/or hemispheric white
matter [55, 62, 63]. In these days of widespread immuniza-
tion, the pediatrician might not consider VZV infection in the
differential of acute neurologic deficits.
There are numerous examples of pre-eruptive chickenpox
causing neurologic complications [31, 67]. In one study [54,
58], 44% of patients with primary VZV infection, docu-
mented by PCR or elevated IgM, had no rash in the 4 weeks
surrounding acute neurologic changes. The differential of
childhood stroke includes metabolic and mitochondrial
disorders, progressive multifocal leukoencephalopathy
(PML), trauma (arterial dissection), and hemolytic uremic
syndrome (HUS). Imaging can be very helpful in narrowing
these considerations. In the setting of diffuse white matter
changes, spectroscopy will show elevated lactate and
decreased NAA. Diffuse white matter signal abnormalities
in children with HIV infection can represent either PML or
VZV infection. The white matter abnormalities of these two
entities differ in that those in VZV vasculitis are usually
smaller and less confluent than seen in PML [60], and in
PML the high signal white matter has a strikingly sharp
interface with the subcortical U-fibers. Trauma is also a
major cause of pediatric stroke. MRA is particularly helpful
in this setting because it can help differentiate the arterio-
pathic changes of VZV vasculitis described above from the
tapering associated with dissection. (Fat-suppressed T1-W
axial source images also nicely show the crescentic bright
T1-W signal of a dissection hematoma.)
We have shown that the range of CNS imaging
manifestations in VZV infection extends from mild cer-
ebellitis to multifocal parenchymal edema to overt stroke.
These different patterns should be familiar to the radiologist
reading pediatric neuroimaging studies. It is also helpful to
understand that these protean manifestations all result from
VZV vasculitis and that patients have different clinical
presentations depending on their pattern of vascular
involvement. Imaging can be the first clue to a diagnosis
of VZV infection and help lead toward PCR confirmation.
This is of particular importance because most experts
recommend treating severe VZV vasculopathy with a
combination of prednisone (60–80 mg/day for 3–5 days)
and intravenous acyclovir (500 mg/m2 body surface area
for a total of 7 days [60]).
Epstein-Barr virus
Virology, clinical course, and CNS manifestations
Like the other herpesviruses, EBV is a ubiquitous pathogen
found in almost all people by the end of their second decade.
The virus infects the nasopharyngeal epithelium and circu-
lating peripheral B lymphocytes. The virus remains dormant
within circulating B-cells but occasionally activates in the
presence of mucosal epithelium, then sheds silently into
infectious saliva. Primary EBV infection is typically asymp-
tomatic in younger children but causes the syndrome of high
fever, tonsillopharyngitis, hepatosplenomegaly, and lymph-
adenopathy characteristic of infectious mononucleosis in
adolescents [68]. About 20% of patients with primary EBV
infection have various complications, and neurologic
involvement occurs in about 5% [7, 69]. Cerebral involve-
ment of EBV infection can range from encephalitis and
meningoencephalitis to optic neuritis [70, 71]. Current
evidence supports an immunologic mechanism rather than
direct viral invasion as the cause of EBV-related CNS
disease [68, 72].
EBV encephalitis/meningoencephalitis
EBV encephalitis is more common than often appreciated
and in the NIAD Collaborative Antiviral Study Group
series was the most common agent to mimic HSE [8]. One
unusual feature of children with EBV encephalitis is that
other than headache and fever, typical symptoms of
infectious mononucleosis are conspicuously absent [68,
70, 71]. Common symptoms include altered consciousness,
visual hallucinations, psychosis, and/or fever [70, 71].
Seizures are present in almost half of patients with EBV
encephalitis [68]. Most children have a benign clinical
course without neurologic sequelae, but about 10% have
residual persistent deficits, and several deaths have been
reported [53, 68, 70, 71]. Some have advocated treatment
with acyclovir and steroids, and although there is little to
support this approach, this may augment supportive care in
some patients [68, 69, 73].
EBV optic neuritis
Optic neuritis is an unusual complication of acute EBV
infection and can occur outside of, or after the onset of,
infectious mononucleosis [74–76]. Like EBV encephalitis,
it is thought that the process is immune-mediated. Involve-
ment can be unilateral or bilateral and is usually retrobulbar
but can extend to the optic chiasm [74]. Antiviral or steroid
treatment has been given, but complete recovery can occur
without treatment [75].
Neuroimaging findings
EBV encephalitis and meningoencephalitis
Neuroimaging will show non-specific areas of decreased
attenuation on CT in a minority of children with EBV
encephalitis [70]. The sensitivity of MRI is better than that
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of CT and will be positive in up to 80% of patients [68] with
multiple foci of T2-W or FLAIR hyperintensity in the
hemispheric cortex, basal ganglia, brainstem, and/or splenium
[68, 70, 71, 75, 77–79] (Fig. 6). EBV has a characteristic
tropism for the deep nuclei and therefore a common and
characteristic pattern is that of increased T2-W signal in the
bilateral thalami and basal ganglia [75, 79–81] (Fig. 6). MRS
is a useful MRI adjunct that might show decreased NAA and
increased levels of myoinositol and amino acid moieties [82].
EBV optic neuritis
EBV associated optic neuritis has non-specific neuroimag-
ing findings of optic nerve edema. The inflammation and
edema are manifest on MRI as increased T2-W signal and
enhancement on T1-W images after contrast agent admin-
istration (Fig. 7). Because the process is immune-mediated,
it can be bilateral and involve the optic chiasm [74].
EBV summary
CNS involvement as a result of EBV infection is associated
with diverse neurologic manifestations including meningi-
tis, meningoencephalitis, cerebellitis, cranial neuritis (optic
nerves and optic chiasm), and occasionally brain stem
encephalitis and myelitis. Reported cerebral sites of
involvement include the striatal body (putamen and caudate
nucleus), thalami, subcortical cerebral white matter, insular
cortex, cerebellar gray matter and white matter, optic nerves
and chiasm, and rarely the brain stem. Fortunately, most
cases are associated with an excellent clinical outcome.
MRI findings of EBV are typically those of T1-W
hypointensity, T2-W hyperintensity, lack of diffusion restric-
tion, and an intact blood–brain barrier. Liberal use of MRS,
particularly in the investigation of basal ganglia involvement,
can sometimes help distinguish between infection, ischemia,
and other toxic/metabolic derangements in many cases.
Cytomegalovirus
Virology, clinical course, and CNS manifestations
Like HSV infection, CMV infection can be congenital or
present later in life, either as primary or recurrent infection.
Although outside the scope of this review, a brief discussion of
congenital CMV infection is appropriate. Congenital CMV
infection is the most common congenital viral infection
worldwide and occurs in about 1 per 100 births [83]. Vertical
transmission across the placenta results in fetal infection, and
the earlier the transmission occurs during gestation, the
poorer the outcome [84]. The vast majority of infected
neonates are asymptomatic, but about 10% present have low
birth weight, hepatitis, pneumonitis, and/or neurologic and
hematologic abnormalities [83, 84]. Congenitally infected
infants can later have failure to thrive and progressive hearing
deficits. Neuroimaging features of congenital CMV infection
include periventricular calcifications, ventriculomegaly,
delayed myelination, hippocampal dysplasia, periventricular
occipital cysts, lissencephaly, and cortical migration abnor-
malities [5, 83, 85, 86]. Neuroimaging abnormalities are an
excellent predictor of poor neurologic outcome [86, 87].
Fig. 6 EBV encephalitis. a Axial FLAIR image demonstrates
abnormal T2-W signal in the bilateral frontal cortex and subcortical
white matter. This is a typical pattern for viral encephalitis. The
multiple vascular territories involved make ischemia unlikely. Addi-
tionally, a child presenting with multifocal strokes of this magnitude
would have a profound clinical presentation with fixed neurologic
deficits. b, c Axial (b) and coronal (c) FLAIR images demonstrate
increased signal in the bilateral basal ganglia reflecting the unique
tropism of EBV for this area
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Outside the context of congenital disease, pediatric
CMV infection occurs most commonly in immunosup-
pressed patients such as those with HIV infection or after
solid organ or bone marrow transplantation. Immunocom-
petent children are rarely affected [88]. If a patient has a
normal immune system, meningoencephalitis is usually the
only CNS manifestation of CMV and is typically self-
limiting [89, 90]. In the immunocompromised, CNS CMV
infection can manifest as meningoencephalitis, ventricu-
loencephalitis, and/or cerebral mass lesions. Diffuse en-
cephalitis is the most common of these and presents with
fever, headache, and non-specific non-focal neurologic
signs such as confusion and memory loss. Immunosup-
pressed patients are more likely to have focal neurologic
signs [88, 91, 92]. Ventriculoencephalitis is particularly
associated with a positive HIV status [88, 91] and typically
has a rapid onset with quick neurologic decline, usually to
coma and death [88]. Accompanying cranial neuropathies
are often seen in these patients and are a clue to the
diagnosis [93]. The rarest form of acute cerebral CMV
infection is that of mass lesions, a very rare presentation
only reported in AIDS patients [94–96].
Neuroimaging findings
The MRI findings of CMV meningoencephalitis are non-
specific and similar to those of other viral encephalitides.
Most investigators describe cortical and/or subcortical areas of
decreased T1-W and increased T2-W signal, usually in the
frontal and parietal lobes [5]. Pathologically, CMV infection
often involves the ependyma and subependyma [97].
Imaging typically shows meningeal enhancement after
administration of gadolinium contrast agent (Fig. 8). In
patients with ventriculoencephalitis, there is also periven-
tricular enhancement [88, 91, 98, 99]. In 1990, Balakrishnan
et al. [97] documented decreased T1-W signal in these
patients and explained that increased T2-W signal was
obscured by adjacent CSF signal. Presumably, with increased
use of FLAIR imaging today, the ventriculitis and periven-
tricular necrosis would be better visualized as increased
ependymal FLAIR signal against dark CSF that has been
suppressed. In cases of ventriculitis, some authors have also
reported ventriculomegaly [99]. The cerebral masses caused
by CMV in AIDS patients manifest as solitary enhancing or
ring-enhancing parenchymal lesions [94, 95, 100].
Fig. 7 Optic neuritis in a child
with elevated EBV IgM titers.
Axial (a) and coronal (b) en-
hanced T1-W images with fat
saturation. Note the enlarged,
enhancing right optic nerve
(arrows). c, d Axial T2-W (c)
and coronal enhanced T1-W (d)
images in another child with
EBV and acute painful ophthal-
moplegia show bilaterally en-
larged and edematous optic
nerves (arrows) with marked
enhancement
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CMV summary
CMV infection should be considered in the immunosup-
pressed child with encephalopathy and non-focal neurologic
signs. The ultimate diagnosis relies on PCR to demonstrate
CMV DNA in the CSF, but imaging has been shown to be
useful in the diagnosis of CMV infection [11]. When the
radiologist sees encephalitis or ventriculoencephalitis in an
immunosuppressed child with non-specific neurologic
signs, the possibility of CMV should be raised and CSF
tested. Prompt treatment of CMV with intravenous antiviral
agents such as ganciclovir or foscarnet has been shown to
improve outcome [101]. Because CMV infections are
largely seen in HIV-positive patients who may have
concomitant HIV encephalitis, differentiation of these two
entities can be difficult. Two things may help: the clinical
deterioration of patients with CMV encephalitis is more
rapid than of those with HIV encephalitis alone, and MRI
can demonstrate ependymal enhancement of the ventricles
and/or parenchymal masses associated with CMV [92]. In
patients with HIV infection and possible lymphoma, CMV
ventriculoencephalitis needs to be differentiated from
lymphoma. Imaging can be helpful in that the periven-
tricular enhancement of infection is usually more thin than
the mass-like enhancement seen in lymphoma [102].
Human herpes virus-6
Virology, clinical course, and CNS manifestations
HHV-6 was discovered in 1986 and has two variants, HHV-
6A and HHV-6B [103]. The latter is associated with
childhood disease and infects almost all children world-
wide. Antibodies to this ubiquitous virus are found in 95%
of the population; most children are infected with the B
variant before the age of 2 years [103]. Primary infection
causes a febrile exanthem known as roseola infantum (sixth
disease) [104], but some patients remain asymptomatic
[105]. The virus enters the body through the salivary
glands, where it replicates and sheds further particles via
infectious saliva. The virus remains latent throughout the
body, including the salivary glands, white blood cells, and
the brain [103, 106–108]. It is well-accepted that the virus
is quite neurotropic [103, 109, 110] and HHV-6 can result
in prolonged, recurrent seizures in a minority of children.
Acute HHV-6B infection is associated with seizures in 13%
of children [107] and causes almost 30% of first-time
febrile seizures in infants. Although the causality of this
relationship is somewhat controversial [111], HHV-6
infection should be considered in children younger than
2 years with first-time febrile seizures [107, 112]. Primary
HHV-6 infection has also been implicated in encephalitis
[113, 114], but more commonly, HHV-6 encephalitis is
encountered in immunosuppressed patients as reactivation.
Reactivation of HHV-6 is seen in 50% of bone marrow
transplant patients [106], usually 2–4 weeks after trans-
plantation [115, 116], but only affects the CNS in a
minority of patients. Patients with reactivation HHV-6
encephalitis present with mental status changes, fever,
seizures, and headache [115]. Care should be taken that
true HHV-6 reactivation is documented in such patients so
as to exclude incidental latent infection coincident with
encephalitis of another etiology. PCR detection of HHV-6
DNA in the CSF of immunocompromised patients with
CNS symptoms has been shown to have a high specificity
[117]. Mortality of HHV-6 encephalitis is more than 50%,
but can be reduced dramatically by prompt treatment with
ganciclovir or foscarnet [115].
Neuroimaging findings
CT findings in patients with HHV-6 encephalitis are usually
negative [115, 118]. MRI is also occasionally negative but
characteristically reveals non-enhancing areas of abnormal
signal in the medial temporal lobes and limbic system,
Fig. 8 Acute CMV meningitis.
This immunocompetent child
had headache, dizziness, mental
status changes and elevated
CMV IgM titers. His CSF was
PCR-negative for EBV and
HSV. a A T1-W image after
administration of contrast agent
shows diffuse leptomeningeal
enhancement (arrows) and no
other abnormalities. b A T1-W
image after administration of
contrast agent obtained coinci-
dentally 1 week prior to admis-
sion for trauma and possible
vertebral dissection was normal
and showed no leptomeningeal
enhancement
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reflecting edema [115, 118, 119]. In particular, bilateral or
unilateral increased T2/FLAIR signal is found in the
hippocampi, amygdala and/or parahippocampal gyrus,
usually without diffusion restriction [118, 120–122]. In
patients without initial MR abnormalities, delayed imaging
usually demonstrates signal abnormalities as described
above [118]. Months after the encephalitis, patients have
resolution of signal abnormalities but persistent volume loss
in the medial temporal lobes [118, 121, 122]. A more
unusual but catastrophic CNS complication of HHV-6 is
basal ganglia involvement with acute necrotizing encepha-
lopathy. This has been reported in multiple infants or very
young children with primary HHV-6 infection. These
children had basal ganglia lesions that were low density
on CT and high T2-W signal on MR. Findings are usually
bilateral and symmetric and involve the striatum [123],
thalami [124], cerebellum, and/or brainstem [125] (Fig. 9).
HHV-6 summary
HHV-6 infection is clinically under-appreciated. Fortunately,
it almost always has a benign course and, other than
associated febrile seizures, CNS complications are rare in
immunocompetent children. On the other hand, HHV-6 can
reactivate in immunosuppressed children and present with
encephalopathy. When these patients have medial temporal
signal changes without enhancement or diffusion restriction
(which are typically seen in HSE), HHV-6 should be
considered.
Summary
Clinicians have long appreciated the diversity of neurologic
disease caused by the human herpesviruses. It is widely
recognized that the herpesviruses cause various acute,
subacute, and chronic disorders of the central and periph-
eral nervous systems. However, rapid clinical recognition
of herpesvirus infection remains elusive. This is particularly
evident with the recognition of neonatal HSE, where
clinical trials demonstrate that the diagnosis can be delayed
more than 5 days from the onset of clinical symptoms in
more than 40% of patients [126]. This delay often leads to
significant morbidity and increased mortality.
Fig. 9 Acute necrotizing en-
cephalopathy in a previously
healthy 8-month-old boy who
presented with rapidly develop-
ing fussiness followed by fever
and seizures. PCR showed
HHV-6-positive CSF but HHV-
6-negative plasma. An initial CT
(not shown) was normal except
for subtle heterogeneous low
density in the basal ganglia. a
Axial T2-W image demonstrates
patchy increased signal in the
bilateral basal ganglia, mainly in
the putamena (white arrows),
thalami (large black arrows),
and caudate heads (small black
arrows). b, c These areas had
true diffusion restriction on
DWI (b) and ADC (c), and no
enhancement on enhanced T1-
W images or hemorrhage by
GRE imaging (not shown). d
Single voxel proton spectrosco-
py over the left basal ganglia
shows decreased NAA (large
arrow), elevated excitatory neu-
rotransmitters (short arrows),
and a lactate peak (thin arrow).
The patient died 2 weeks after
admission
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The union of detailed health history, physical examina-
tion, early CNS MRI, and established virologic and
molecular PCR techniques leads to more timely diagnoses
and prompt implementation of therapy. Current clinical
MRI of the CNS at 1.5 and 3.0 T using eight-channel head
coil technology provides the foundation of detailed ana-
tomic information in the setting of suspected CNS viral
infection. Adjunctive MRI techniques such as DWI and
MRS contribute valuable information regarding cell viabil-
ity and the biochemical milieu of the region sampled. The
synthesis of anatomic and physiologic information often
aids the radiologist in distinguishing infection from infec-
tious mimics such as ischemic, toxic, or metabolic insults.
Although overlap in the clinical expression of the
herpesviruses is a fact well known to clinical practitioners,
there are distinct neuroimaging findings that provide
helpful diagnostic clues among this virus family. This
review attempts to highlight the clinical features and
characteristic imaging findings of the expanding spectrum
of human herpesvirus infections of the CNS in neonates,
infants, and children.
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